DXR

Daxor Corporation (DXR)

NASDAQ
$12.68
$--
(0.00%)
Daxor Corporation (DXR) Live Price Chart
Page last updated: 2026-02-12 20:09:00

Key Market Data

$63.86M

$12.48

$24.60

$3.40

$12.59

--

0.00%

3K

Daxor Corporation (DXR) Stock Price Today

Daxor Corporation (DXR) is currently trading at $12.68 as of 2026-02-12 20:09:00, reflecting a 0.00% move ($-0.00) from the previous close.

In the short term, the stock has returned -594.74% over the past four weeks. Over the last 12 months, Daxor Corporation has recorded a +79.79% price change, indicating a strong performance relative to the broader market.

Daxor Corporation (DXR) 7-Day Stock Price Changes

Over the past seven days, Daxor Corporation has traded within a short-term range shaped by market sentiment in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. During this period, the stock moved from its previous closing price of $12.35 to the latest recorded price of $12.68, reflecting an intraday change of 0.00%. Daily movements highlight shifts in trading volume (2,848), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, DXR has delivered a -594.74% return over the past month and a +79.79% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy Daxor Corporation (DXR)

You can buy and trade DXR on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account
Step 1: Create and Verify Your MEXC Account
Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.
Step 2: Deposit Funds Into Your Account
Step 2: Deposit Funds Into Your Account
Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.
Step 3: Search for DXR and Execute Your Trade
Step 3: Search for DXR and Execute Your Trade
Open the trading page, enter DXR in the search bar, select the amount of DXR you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Daxor Corporation (DXR)?

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Daxor Corporation Information

Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
750
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Company Website

Frequently Asked Questions (FAQ)

1.What is the current share price of Daxor Corporation?
The latest trading price for Daxor Corporation (Common Stock) is $ 12.68, compared with a previous closing price of $ 12.59. That means the stock has moved 0.00% so far today. Intraday price updates and recent trading activity for DXR can be tracked on the live chart and quote section on this page.
2.Is Daxor Corporation stock going up or down?
Looking at recent performances, DXR has returned -594.74% over the past month, +15.02% over the last six months and +79.79% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for Daxor Corporation stock, but keep in mind that past returns do not guarantee future results.
3.Where does DXR currently sit relative to its 52-week high and low?
In the most recent 52-week period, Daxor Corporation has traded between a low of $ 6.80 and a high of $ 14.76. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether DXR is currently nearer the top or the bottom of its one-year trading band.
4.How is Daxor Corporation classified by sector and industry?
Daxor Corporation is classified in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. In practice, this means Daxor Corporation is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing DXR’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector could influence Daxor Corporation’s performance.
5.Where is Daxor Corporation listed and how large is it by market value?
Daxor Corporation is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 63.86M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Daxor Corporation's size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.
6.What does DXR's EPS tell investors about its profitability?
Trailing-twelve-month EPS of $ -0.62 summarises how much profit Daxor Corporation has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.
7.How can I track Daxor Corporation's financial performance over time?
To follow Daxor Corporation's financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how DXR is performing and how the market is responding.
8.When is Daxor Corporation expected to report earnings?
Daxor Corporation's next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for DXR, as they provide updated information on revenue, profitability and management's outlook.
9.What usually comes out in Daxor Corporation's earnings reports?
Daxor Corporation's earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether DXR is meeting, beating or missing expectations.
10.How can I stay informed about Daxor Corporation's results and guidance?
You can stay up to date on Daxor Corporation by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for DXR on this page helps you see how new information is being reflected in the stock.
11.Does Daxor Corporation pay a regular cash dividend to its shareholders?
Daxor Corporation Paying. Based on the latest information, the stock has an indicated annual cash dividend of $ 0.57 per share and a current dividend yield of 0.0446 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor DXR's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.
12.What are the current dividend yield and dividend payout ratio for DXR?
Based on the latest earnings data, DXR has a dividend yield of 0.0446 and a dividend payout ratio of -0.9118. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Daxor Corporation is an attractive income stock. The dividend payout ratio measures what percentage of earnings Daxor Corporation distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.
13.What kind of business is Daxor Corporation?
Daxor Corporation is a publicly traded company in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry within the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.
14.How is DXR valued in terms of P/E ratio and EPS?
Daxor Corporation currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.62. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Daxor Corporation's earnings. Comparing DXR's P/E and EPS to those of other SURGICAL & MEDICAL INSTRUMENTS & APPARATUS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Daxor Corporation

Largest Market Cap

See US stocks with the highest market capitalization

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

DXR-to-USD Calculator

Amount

DXR
DXR
USD
USD

1 DXR = 12.675 USD